Yeast Infections Market is Growing Solidified CAGR of 5.2% During Forecast to 2023


Market Analysis:
Such yeasts are generally present in the intestine, the vagina, and on the skin. Under normal conditions, this yeast will not cause any infection, yet at times can lead to an infection in the skin, vagina, or mouth owing to several factors of which the most common include a conducive environment, unhygienic conditions, weak immune response, amid others. Along with infants, those suffering from inflammatory disorders, hypothyroidism, obesity, and diabetes are susceptible to catching this infection. Yeast infection is most common in those areas of the skin that are humid. 
The Yeast Infection Market is predicted to grow at a 5.2% CAGR over the forecast period (2018-2023), states the new Market Research Future (MRFR) report. Yeast infection which is popularly known as candidiasis is a form of infection that results from different forms of yeast known as Candida.
Various factors are propelling the yeast infection market growth. Some of these factors according to the Market Research Future (MRFR) report, include rising incidence of autoimmune diseases, rising geriatric population, rising cases of HIV, government support for R&D, and growing demand for antifungal drugs. Additional factors pushing market growth include growing prevalence of infections, the widespread use of antibiotics, growing awareness, availability of new treatment and medications, technological advancements in medical science, pollution and unhealthy lifestyle, and increasing investments made in research and development activities. 
On the contrary, side effects associated to the treatment, complications during treatments, drug resistance, and unmet clinical needs are factors that are likely to impede the yeast infection market growth over the forecast period. 
Key Players:
·         AstraZeneca
·         ALLERGAN
·         Sanofi
·         Pfizer Inc
·         Novartis AG
·         Abbott
·         Mentis Pharma Ltd
·         Bayer AG
·         Astellas
·         Merck & Co
·         Synmedic Laboratories
·         Scynexis
Market Segmentation:

·         The MRFR report provides a complete segmental analysis of the yeast infection market on the basis of end users, treatment, types, and pathogen. 

·         Based on pathogen, the yeast infection market is segmented into candid rugosa, candida glabrata, candida albicans, and others. 

·         Based on type, the yeast infection market is segmented into throat yeast infection, skin yeast infection, vaginal skin infection, and others. 

·         Based on treatment, the yeast infection market is segmented into surgery and drug treatment. The drug treatment segment is further segmented into suppository, tablet, ointment, and cream. 

·         Based on end users, the yeast infection market is segmented into ambulatory centers, clinics, hospitals, and others. 
Regional Analysis:
By region, the yeast infection market report covers the latest trends and growth opportunities across Europe, the Americas, the Asia Pacific, and the Middle East and Africa. Of these, the Americas will spearhead the market over the forecast period. This is due to the rising cases of patients suffering from immune diseases and the presence of a vast geriatric population. 

The yeast infection market in Europe is predicted to have the second-largest share over the forecast period. This is chiefly due to the accessibility of government support for R&D and the availability of modern treatment facilities. 

The yeast infection market in the APAC region is predicted to have a notable growth over the forecast period. This is owing to the growing prevalence of HIV in the region, growing awareness about yeast infections and the accessibility of new treatment methods. China, as well as India, are the key contributors in this region. 

The yeast infection market in the Middle East and Africa is predicted to have minimal growth over the forecast period. This is owing to a lack of awareness and limited availability and access to treatment facilities. 


Comments

Post a Comment

Popular posts from this blog

Proteomics Market Analysis, Demand Overview, Growth Analysis, Current Trends, Updates, and Global Industry Forecast to 2023

Market Highlights: The global proteomics market is anticipated to hold a market value of USD 23.2 billion in the year 2017 and is expected to grow at a CAGR of 14.1% during the forecast period. Proteomics is a science which is used to estimate the rate of protein production, interaction of proteins with one another, involvement of proteins in metabolic pathways, and modification of proteins. Also, it has extensive applications in drug discovery, development of personalized medicines, and identification of markers for disease diagnosis. Increasing need for personalized medicine, R&D expenditure, technological advancements and increased funding for proteomics project are expected to drive the market growth over the forecast period. For instance, in July 2017, Biognosys AG received USD 5 million funding from its new as well as existing investors. These new funds will be used for extending commercial operations and also to accelerate the development of next generation prote...
Read more

Pancreatic Cancer Market: America to Command the Largest Share

Market Overview: Pancreatic cancer can be defined as an enlarged tumor, which is generally caused by malignant cells present in the tissues of the pancreas. This type of cancer is generally caused due to drinking alcohol, smoking, genetic factors, radiotherapy in the past, obesity, inflammation of the pancreas, and diabetes mellitus. It is a type of cancer that starts in the pancreas and is a highly lethal disease. The global Pancreatic Cancer Market , as per a report by Market Research Future (MRFR) is touted to register 8.1% CAGR during the forecast period ( 2017-2023 ). The dearth of therapeutic approaches for early-stage detection has resulted in increased incidences of pancreatic cancer. Soaring prevalence of pancreatic cancer has resulted in germline mutations, thereby causing the defective genes to pass down to the children from their parents, thus making early detection of pancreatic cancer important. This has led to the growth of the market across the globe. Surging dem...
Read more

Immune Thrombocytopenia (ITP) Market is Estimated to Record Promising CAGR of 5.78% During Forecast 2018-2023

Market Highlights: As per the latest report published by Market Research Future (MRFR), the Global Immune Thrombocytopenia (ITP) is set to surpass a valuation of USD 2,300 Mn by the year 2023, reflecting a healthy CAGR. ITP is a blood related disorder that cause abnormal clotting. Some of the discomforts caused by the disease include bruising, bleeding and severe drop in platelets counts. Both minors and adults can develop the condition. The disease is classified into primary and secondary form. Primary form of ITP occurs on its own while the latter is an offshoot of another condition. The condition can be triggered by reactive medications, autoimmune disease, pregnancy and certain type of cancers. ITP is among the most commonly occurring disorder across the globe. In addition, the incidence rate has continued to spiral upwards in recent years. Factors as such as are fueling the demand for drugs and therapeutics for ITP. Currently, there are four treatment options available for ...
Read more